AI that measures and tracks tumors for you.

Click on a lesion on a CT scan anywhere in the body – iMeasure measures and segments it instantly, and tracks it across follow-up scans. Hours of manual work, done in minutes, with outputs you can rely on across readers, sites and timepoints.

One-click measurement
< 1s
2D segmentation performance 0.92
Any organ, chest & abdomen 5+
Integration 1 API

The problem

Lesion tracking across the body is a tedious, manual and time consuming task.

Measurements are time-intensive and expert-dependent

Measuring target lesions and assessing changes over time takes specialised radiologist time – repeated across every follow-up scan.

Building measurement AI in-house is a distraction

Viewer and platform teams spend years building and validating segmentation models – instead of shipping the workflow their users actually pay for.

High inter- and intra-reader variability

RECIST 1.1 measurements are subjective. Different observers – or the same observer on different days – routinely disagree on the same lesion.

Measurements miss the full picture

Uni-dimensional measurements ignore tumour morphology, density and volume – losing signal that matters for response assessment.

The product

A promptable AI model for solid tumor evaluation, insights and tracking.

Lesion identification

One click in your viewer to indicate lesion location


Two axial measurements returned automatically in under a second


2D or 3D findings – any organ in the chest or abdomen

Longitudinal tracking

Registration-based matching follows the same lesion across baseline and follow-up scans


Consistent measurements at every timepoint – the foundation for reliable trend data


Dynamics, per-lesion history and multi-timepoint views render natively in your viewer’s finding and reporting workflow

RECIST-ready measurements

Standardised, reproducible measurements your RECIST 1.1 workflow can rely on


Target lesion sums, % change and response derivation supported by consistent inputs across readers and sites


Full automated RECIST 1.1 reporting available out of the box in BMViewer

Structured data out, on every call

All lesion metrics returned as structured data – ready for your reporting, archive or trial database


Annotated images stored on the fly


Available via API for any standard viewer; BMViewer available as an end-to-end option

Segmentation performance

Strong DICE scores across organs – and continuously improving.

2D performance

Kidneys

0.92

Pancreas

0.89

Lungs

0.82

Liver

0.78

Mean DICE. Subject to continuous improvement.

3D performance

Kidneys

0.85

Lungs

0.82

Pancreas

0.81

Liver

0.77

Lymph nodes

0.71

Mean DICE. Subject to continuous improvement.

Use cases

Built to be built in.

iMeasure is sold as an API, designed for the platforms radiologists already work in.

Clinical trial imaging platforms

Standardise RECIST 1.1 reads across sites and readers. Integrate iMeasure into the viewer your CRO customers’ radiologists use – consistent measurements feed your existing response-assessment workflow.

Viewer & PACS component providers

Add one-click lesion measurement and longitudinal tracking to your product – without building and validating an AI pipeline in-house.

Lung cancer screening platforms

Screening means heavy, repetitive reporting across many timepoints. Automated measurement and registration-based tracking cut the per-round reporting load where it’s largest.

Radiotherapy & surgical planning

Organ and lesion segmentation to support planning and to assess change over the course of treatment.

Build with us

Three concrete ways to work with us on iMeasure.

Whether you’re a hospital, a CRO or a pharma sponsor – we’d love to talk about how iMeasure fits your workflow.

API integration

Add lesion segmentation, volumetric measurement and longitudinal tracking to your own viewer – through our API.

BM Viewer

Don’t have a viewer to integrate into? Get iMeasure ready to use in BMViewer, with full RECIST 1.1 reporting built in.

Clinical trial support

Use iMeasure to standardise RECIST 1.1 reads across sites and readers in oncology trials.